Business
OTC Markets Group Welcomes New OTCQB Companies – July 20
OTC Markets Group Welcomes New OTCQB Companies – July 20.
About this update from Grapefruit Usa Inc.
[{"type":"text","content":"OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, announced the following companies are approved for trading on the OTCQB Venture Market:Grapefruit USA, Inc. (OTCQB: GPFT) Grapefruit USA, Inc. (\"Grapefruit\") is a DE corporation whose shares trades under the symbol \"GPFT\". GPFT is a \"Reporting Company\". Grapefruit holds licenses issued by the State of California in January 2018 to both manufacture and distribute cannabis products.Grapefruit's corporate headquarters is in L.A. Grapefruit owns and operates a CA licensed cannabis extraction laboratory and distribution facility in the Coachillin' Canna-Business Park, near Palm Springs, California. The Company's extraction lab produces high quality, cannabis-derived THC distillates commonly known as \"honey oil\" and \"crude oil\" from cannabis flower and \"trim\". These distillates are base cannabis commodities, which are the active ingredients in many cannabis products including infused edibles, tinctures, creams, and is also used as the active ingredient in vaporization cartridges. Grapefruit also distributes cannabis and cannabis products to other properly licensed cannabis product companies. Grapefruit is developing its \"patchless patch\" which provides users with a defined \"time release\" dose of THC. This product is expected to be released in the third quarter of 2020.Microbix Biosystems Inc. (TSE: MBX; OTCQB: MBXBF) Microbix develops proprietary biological and technology solutions for human health and well-being, with approximately 80 skilled employees and sales now exceeding $1 million per month on average. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure quality control of clinical diagnostic tests. Microbix antigens enable the antibody tests of over 100 international diagnostics companies, while its QAPs are sold to clinical laboratory accreditation organizations, diagnostics companies, and clinical laboratories. Microbix QAPs are now available in 22 countries, distributed by Alpha-Tec Systems, Inc., Diagnostic International Distribution S.p.A., Labquality Oy, The Medical Supply C...